Core Viewpoint - XMax Inc. reported significant growth in net sales and a reduction in net loss for the third quarter of 2025, highlighting both challenges and opportunities in the current market environment [2][5]. Financial Performance - Net sales for the three months ended September 30, 2025, increased by 273% to $9.76 million, up from $2.62 million in the same period of 2024 [5]. - Gross profit for the same period was $0.98 million, a decrease from $1.18 million in the third quarter of 2024 [5]. - The net loss for the third quarter was $1.13 million, improved from a net loss of $2.47 million in the same period of 2024 [5]. Year-to-Date Performance - For the nine months ended September 30, 2025, net sales grew by 95% to $14.95 million, compared to $7.68 million in the same period of 2024 [5]. - Gross profit for the nine-month period was $3.47 million, slightly up from $3.39 million in the same period of 2024 [5]. - The net loss for the nine months was $1.76 million, improved from a net loss of $4.49 million in the same period of 2024 [5]. Company Overview - XMax Inc., headquartered in Commerce, California, is a distributor of contemporary styled residential and commercial furniture, focusing on integrating popular design trends into its product lines [3]. - The company serves a global customer base through a network of retailers, e-commerce platforms, and hospitality providers [3]. Strategic Developments - The successful completion of a $9.0 million public offering is noted as a commitment to exploring new opportunities and enhancing long-term shareholder value [2].

MIRAMAR, Fla., Nov. 14, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and diseases, today reported financial results and recent business highlights for its third quarter ended September 30, 2025. The Company anticipates dosing the first patient in a Phase 1 clinical study (NCT07049328) to eva ...

KAPALUA, Hawaii , Nov. 14, 2025 (GLOBE NEWSWIRE) -- Maui Land & Pineapple Company, Inc. (NYSE: MLP) today reported financial results covering the quarter ended September 30, 2025. "Our third-quarter results reflect the successful execution of our strategic initiatives, highlighted by a 39% increase in recurring leasing revenue year-over-year. This remarkable growth was complemented by strong progress in our land development segment, demonstrating our commitment to unlocking the value of our assets and accel ...

Core Insights - Jet.AI Inc. reported its third-quarter financial results for 2025, highlighting a significant decrease in revenues and ongoing progress in its Canadian Hyperscale Data Center Project [1][5][10]. Financial Performance - Revenues for Q3 2025 were $1.7 million, down from $3.9 million in Q3 2024, primarily due to reduced revenue from Cirrus Charter and Jet Card services [5][10]. - For the nine months ended September 30, 2025, total revenues were $7.4 million, compared to $10.8 million in the same period last year, reflecting a similar trend of declining revenues [10][11]. - The company reported a gross loss of approximately $288,000 for Q3 2025, compared to a loss of $14,000 in Q3 2024, driven by reduced flight activity without a corresponding decrease in fixed costs [8][20]. - Operating expenses decreased to $1.7 million in Q3 2025 from $2.9 million in Q3 2024, mainly due to lower general and administrative expenses [8][20]. - As of September 30, 2025, Jet.AI had cash and cash equivalents of approximately $3.5 million, down from $5.9 million at the end of 2024 [9][18]. Operational Highlights - The company successfully completed the second milestone of its Canadian Hyperscale Data Center Project and is making significant progress towards the third milestone [4][6]. - The Transmission Power Load Study application for the Midwestern Project is nearly complete, and discussions with the natural gas utility supplier are ongoing [4]. - For the Maritime Project, negotiations with a power producer are advancing towards a Letter of Intent (LOI) to acquire power from a proposed wind farm [4]. Strategic Initiatives - Jet.AI's management emphasized the successful closing of the AI Infrastructure Acquisition Corp.'s IPO, which added approximately $20 million to the company's book equity [3][6]. - The company has extended the outside date for its merger agreement with flyExclusive to December 31, 2025, amid a government shutdown affecting SEC reviews [3][6].

Core Viewpoint - Beam Global reported a significant decrease in revenues for Q3 2025, largely attributed to unfavorable order timing, while simultaneously making strategic expansions into the Middle East and enhancing its product offerings for electric mobility solutions [4][6][7]. Recent Operational Highlights - The company opened offices in the Middle East and entered the MEA market through a joint venture in Abu Dhabi [5]. - Beam Global deployed EV ARC™ and BeamBike™ systems in Abu Dhabi and BeamWell™ in Jordan for the Royal Jordanian Armed Forces [5]. - The company signed reselling agreements in the U.S. and Europe and renewed its GSA Multiple Award Schedule contract through October 2030 [5]. - Beam Global received several new patents, enhancing its competitive position [5]. Financial Highlights - For Q3 2025, revenues were $5.8 million, a 50% decrease from $11.5 million in Q3 2024, with 82% of revenues coming from non-government commercial entities [6]. - For the first nine months of 2025, revenues decreased 53% to $19.2 million compared to $40.9 million in the same period in 2024, with non-government commercial revenues growing to 67% [7]. - Gross margin for Q3 2025 was -1%, compared to 11% in Q3 2024, while adjusted non-GAAP gross margin was 22%, a 4-percentage point increase from the previous year [8][9]. - Operating expenses for Q3 2025 were $4.8 million, a significant reduction from $11.6 million in Q3 2024, reflecting improved operational efficiencies [11]. - The net loss for Q3 2025 was $4.9 million, compared to a net profit of $1.3 million in Q3 2024 [13]. Cash Position - As of September 30, 2025, the company had cash of $3.3 million, down from $4.6 million at the end of 2024, with working capital of $10.9 million [15].

NESS ZIONA, Israel, Nov. 14, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies targeting specific pathogenic bacteria, today announced that it intends to effect a one-for-nineteen reverse split (the "Reverse Stock Split") of the Company’s common stock (the "Common Stock"). The Common Stock will continue to trade on the NYSE American under the existing symbol “PHGE” and will begin trading on a ...

Core Insights - XWELL, Inc. reported third-quarter revenue of approximately $7.3 million for the period ending September 30, 2025, with significant improvements in cost management and operational efficiency [6][15] - The company is expanding its wellness services beyond airport locations, with new centers opening in Florida and New York City, enhancing accessibility for consumers [3][7][14] - XWELL has streamlined its corporate cost structure, reducing annualized staffing costs by approximately $2.4 million, and integrated its HyperPointe™ business to optimize resources [4][5] Recent Operating Highlights - The CEO emphasized progress in diversifying access points and enhancing brand relevance, particularly through partnerships like the expanded collaboration with Priority Pass [3] - New off-airport wellness centers have been opened, including locations in Penn Station, New York, and various Florida markets, aimed at serving local consumers [3][6][7] Financial Overview - Revenue breakdown for Q3 2025: approximately $5.1 million from XpresSpa, $1.7 million from XpresCheck, and $0.5 million from Naples Wax Center [15] - Cost of sales decreased by about 8% compared to the same quarter in 2024, while general and administrative expenses fell by approximately 32% [6][15] - The operating loss for the quarter was approximately $0.8 million, a significant reduction from the $4.8 million loss in the prior year [15] Strategic Initiatives - XWELL's partnership with Priority Pass has expanded to key international airports in the Middle East and Europe, enhancing traveler access to wellness offerings [6][7] - The company is leveraging its biosecurity program, XpresCheck, to capture growth opportunities in travel and mass-gathering settings, including major global events [8][9][10] Liquidity and Financial Condition - As of September 30, 2025, XWELL had approximately $4.0 million in cash and cash equivalents, with total current assets of about $10.8 million and no long-term debt [11]

Core Insights - PetVivo Holdings, Inc. reported a 51% increase in revenues for the second quarter of fiscal year 2026, totaling $303,000, driven by the introduction of the new product line PrecisePRP and expansion into the companion animal market [7][19][21] - The company has successfully entered the European market through a partnership with Nupsala Group, enhancing its distribution capabilities [6][16] - PetVivo's strategic collaborations, including with Digital Landia and Commonwealth Markets, are expected to enhance product adoption and market presence [10][17][18] Fiscal Q2 Financial Highlights - Revenues increased to $303,000, up 51% from the same quarter last year, marking a record for the second fiscal quarter [7][19] - Gross profit rose to $220,000, with a gross margin of 72.6%, an improvement from 63.8% in the previous quarter [20] - Operating loss increased to $2.1 million, while net loss rose to $3.0 million, reflecting increased sales and marketing expenses [21][22] Fiscal Q2 Operational Highlights - The company engaged additional distributors to support domestic and international expansion, with national distributor network sales increasing by 35% [7][19] - PetVivo's flagship product, Spryng with OsteoCushion Technology, has been adopted by over 1,200 veterinary clinics across the U.S. [17] - The company launched three new continuing education courses for veterinary professionals to enhance expertise in osteoarthritis and regenerative modalities [13] Strategic Partnerships and Innovations - A strategic partnership with Digital Landia aims to integrate AI technology into PetVivo's veterinary products, potentially reducing client acquisition costs significantly [10][18] - The collaboration with Commonwealth Markets has led to the integration of Spryng and PrecisePRP into care protocols for thoroughbred horses [17] - Ongoing research with PiezoBioMembrane is focused on developing biodegradable piezoelectric materials for regenerative applications [12][15] Financial Outlook - Management anticipates continued record growth for the full fiscal year ending March 31, 2026, driven by the expansion of Spryng and PrecisePRP [24][25] - The U.S. animal health market is projected to double to $11.3 billion by 2030, providing significant growth opportunities for PetVivo [18]

Frontline plc (the “Company”) announces that its 2025 Annual General Meeting will be held on December 8, 2025. A copy of the Notice of Annual General Meeting and associated information including the Company’s Annual Report on Form 20-F for 2024 can be found on our website at www.frontlineplc.cy and attached to this press release. November 14, 2025Limassol, Cyprus This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachments FRO - Not ...

SINGAPORE, Nov. 15, 2025 (GLOBE NEWSWIRE) -- BGIN BLOCKCHAIN LIMITED (“BGIN” or the “Company”; NASDAQ: BGIN), a digital asset technology company with proprietary cryptocurrency mining technologies and an innovator in cryptocurrency mining hardware and infrastructure, today released its unaudited financial results for the six months ended June 30, 2025 (“1H 2025”). 1H 2025 Financial Highlights Total revenue was US$47.7 million, compared with US$144.5 million in the same period of 2024.Mining revenue increase ...